Skip to content

DaVita Inc.

DVA· NYSECore metricsCIK 927066

Miscellaneous health & allied services13 peers

Last sale
Nov 12, 2026 · -4.97%
Market cap
$10.97B
62.9M shares
Filings
1,045
$3.58B
Q3 2026+6.5% FY25 yoy
$222.93M
Q3 2026−20.2% FY25 yoy
$499.26M
Q3 2026−2.2% FY25 yoy
$898.41M
Q3 2026derived−10.6% FY25 yoy
$3.40
Q3 2026−8.3% FY25 yoy
$495.63M
Q3 2026−14.9% FY25 yoy
$10.97B
11.9×
0.8×
—
11.80%
—

Twelve months to Sep 30, 2026 · derived

Price

$174.34+42.64%+$52.12past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of record

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$13.64BFY 2025
$13.64B0FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$13,643,069,000reported
FY 20242024-12-31$12,815,550,000reported
FY 20232023-12-31$12,140,147,000reported
FY 20222022-12-31$11,609,894,000reported
FY 20212021-12-31$11,618,797,000reported
FY 20202020-12-31$11,550,604,000reported
FY 20192019-12-31$11,388,479,000reported
FY 20182018-12-31$11,404,851,000reported
FY 20172017-12-31$10,876,634,000reported
FY 20162016-12-31$10,707,467,000reported

Capital returns

Dividends and buybacks · FY2016 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025$0.00$1.31B$1.31B—66.80M sh−16.5%99.8%
FY2024$0.00$1.39B$1.39B—80.00M sh−8.8%94.5%
FY2023$0.00$272.22M$272.22M—87.70M sh−3.0%18.3%
FY2022$0.00$802.23M$802.23M—90.40M sh−6.1%83.5%
FY2021$0.00$1.54B$1.54B—96.30M sh−12.0%119.3%

Segments

Segments
Revenue by Segments, FY2018 to FY2025FY2018U S Dialysis · FY2018 · $10.24BOther - Ancillary services · FY2018 · $1.16BFY2019U S Dialysis · FY2019 · $10.43BOther - Ancillary services · FY2019 · $957.90MFY2020U S Dialysis · FY2020 · $10.51BOther - Ancillary services · FY2020 · $1.04BFY2021U S Dialysis · FY2021 · $10.58BOther - Ancillary services · FY2021 · $1.04BFY2022U S Dialysis And Related Lab Services with Intersegment · FY2022 · $10.60BU S Dialysis · FY2022 · $10.51BOther Operating Segments with Intersegment · FY2022 · $1.10BOther - Ancillary services · FY2022 · $1.10BFY2023U S Dialysis And Related Lab Services with Intersegment · FY2023 · $10.94BU S Dialysis · FY2023 · $10.85BOther Operating Segments with Intersegment · FY2023 · $1.30BOther - Ancillary services · FY2023 · $1.29BFY2024U S Dialysis And Related Lab Services with Intersegment · FY2024 · $11.39BU S Dialysis · FY2024 · $11.32BOther Operating Segments with Intersegment · FY2024 · $1.51BOther - Ancillary services · FY2024 · $1.50BFY2025U S Dialysis And Related Lab Services with Intersegment · FY2025 · $11.79BU S Dialysis · FY2025 · $11.73BOther Operating Segments with Intersegment · FY2025 · $1.92BOther - Ancillary services · FY2025 · $1.91B
LineFY2025ShareChange
U S Dialysis And Related Lab Services with Intersegment$11.79B86%+3.5%
U S Dialysis$11.73B86%+3.6%
Other Operating Segments with Intersegment$1.92B14%+27.3%
Other - Ancillary services$1.91B14%+27.7%
Total$13.64B

From the 10-K filed Feb 11, 2026DVA

Miscellaneous health & allied services

DaVita Inc. is the largest of the 14 covered companies the SEC files under this code, by revenue. SIC 8090

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

DaVita Inc. · CIK 927066 · Engraved from SEC EDGAR